Update shared on31 Jul 2025
Fair value Decreased 7.01%Chemed’s analyst price target has been modestly reduced, as a lower future P/E multiple has more than offset improved revenue growth forecasts, bringing fair value down to $597.50.
What's in the News
- Chemed repurchased 75,000 shares for $42.9 million in Q2 2025, completing a total buyback of 11,053,146 shares (62.45%) under its longstanding program.
- The company lowered its 2025 diluted EPS guidance (excluding certain items) to $22.00–$22.30, down from the previous $24.95–$25.45 range.
- A shareholder proposal regarding special meeting improvements was withdrawn after the proponent failed to appear at the annual meeting.
Valuation Changes
Summary of Valuation Changes for Chemed
- The Consensus Analyst Price Target has fallen slightly from $610.00 to $597.50.
- The Future P/E for Chemed has fallen from 27.42x to 25.50x.
- The Consensus Revenue Growth forecasts for Chemed has risen slightly from 5.0% per annum to 5.3% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.